Evaluation of circulating tumor cells in stage III colorectal cancer patients under three or six months of adjuvant therapy.

被引：0
|
作者：
Messaritakis, Ippokratis
Koulouridi, Asimina
Sfakianaki, Maria
Vogiatzoglou, Konstantinos
Gouvas, Nikolaos
Tsiaousis, Ioannis
Athanasakis, Elias
Xynos, Evangelos
Sougklakos, Ioannis
Boukovinas, Ioannis
机构：
[1] Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Greece
[2] Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Dept Translat Oncol, Iraklion, Greece
[4] Univ Cyprus, Nikosia, Cyprus
[5] Univ Crete, Iraklion, Greece
[6] Univ Hosp Heraklion, Iraklion, Greece
[7] Creta Interclin Hosp, Iraklion, Greece
[8] Univ Heraklion, Iraklion, Greece
[9] Bioclin Thessaloniki, Thessaloniki, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15601
引用
收藏
页码：E15601 / E15601
页数：1
相关论文
共 50 条
  • [21] Is there alternative to FOLFOX adjuvant chemotherapy for stage III colorectal cancer patients?
    Esch, Anouk
    Coriat, Romain
    Perkins, Geraldine
    Brezault, Catherine
    Chaussade, Stanislas
    PRESSE MEDICALE, 2012, 41 (01): : 51 - 57
  • [22] Circulating tumor cells in adjuvant breast cancer patients.
    Almokadem, S
    Leitzel, K
    Harvey, HA
    Bannon, E
    Ali, SM
    Miller, C
    Repollet, M
    Allard, WJ
    Terstappen, LWWM
    Lipton, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 45S - 45S
  • [23] Serial circulating tumor DNA analysis to assess recurrence risk, benefit of adjuvant therapy, growth rate and early relapse detection in stage III colorectal cancer patients.
    Henriksen, Tenna V. Vesterman
    Tarazona, Noelia
    Frydendahl, Amanda
    Reinert, Thomas
    Carbonell-Asins, Juan Antonio
    Sharma, Shruti
    Renner, Derrick
    Roda, Desamparados
    Huerta, Marisol
    Rosello, Susana
    Gotschalck, Kare Andersson
    Iversen, Lene H.
    Love, Uffe S.
    Thorlacius-Ussing, Ole
    Sethi, Himanshu
    Aleshin, Alexey
    Cervantes, Andres
    Andersen, Claus Lindbjerg
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
    Malesci, Alberto
    Bianchi, Paolo
    Celesti, Giuseppe
    Basso, Gianluca
    Marchesi, Federica
    Grizzi, Fabio
    Di Caro, Giuseppe
    Cavalleri, Tommaso
    Rimassa, Lorenza
    Palmqvist, Richard
    Lugli, Alessandro
    Koelzer, Viktor. H.
    Roncalli, Massimo
    Mantovani, Alberto
    Ogino, Shuji
    Laghi, Luigi
    ONCOIMMUNOLOGY, 2017, 6 (12):
  • [25] Timing of adjuvant therapy in stage II-III colorectal cancer.
    dos Santos, Lucas Vieira
    Faria, Thaissa Veiga
    Lima, Andre Bacellar Costa
    Abdalla, Kathia Cristina
    Viana, Vivian de Araujo
    Tavares, Isabela R.
    de Moraes, Eduardo Dias
    Melani, Armando
    Cruz, Marcelo Rocha
    Lima, Joao Paulo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Recurrent disease in patients with stage III melanoma in the era of adjuvant immune and targeted therapy.
    Lo, Victor
    Francescutti, Valerie
    McWhirter, Elaine
    Farrokhyar, Forough
    Lee, Linda May
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Real-world adoption of 3 months of adjuvant oxaliplatin chemotherapy in patients with stage III colorectal cancer (CRC).
    Krishnan, Tharani
    Vasconcelos, Joao Paulo Solar
    Lim, Howard J.
    Loree, Jonathan M.
    Davies, Janine Marie
    Gill, Karamjit
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 83 - 83
  • [28] Author Correction: Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer
    Jiazi Yu
    Mian Yang
    Tao Peng
    Yelei Liu
    Yuepeng Cao
    Scientific Reports, 14
  • [29] Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection
    Yu, Jun-Hui
    Wang, Dong
    Jin, Lan
    Wang, Jin
    Zhao, Xiao-Mu
    Wu, Guo-Cong
    Yao, Hong-Wei
    Yang, Ying-Chi
    Zhang, Zhong-Tao
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1487 - 1494
  • [30] Adjuvant therapy in patients with stage II and III colon cancer under 70 years of age
    Dumont, Sarah N.
    Chibaudel, Benoist
    Bengrine-Lefevre, Leila
    Andre, Thierry
    de Gramont, Aimery
    COLORECTAL CANCER, 2013, 2 (03) : 205 - 217
12345